Rates and determinants of virologic and immunological response to HAART resumption after treatment interruption in HIV-1 clinical practice.
OBJECTIVE: To describe CD4 and HIV RNA changes during treatment resumption (TR) after treatment interruption (TI) compared with response to first highly active antiretroviral therapy (HAART) and to investigate predictors. METHODS: Using Concerted Action on SeroConversion to AIDS and Death in Europe...
Hlavní autoři: | Touloumi, G, Pantazis, N, Stirnadel, H, Walker, A, Boufassa, F, Vanhems, P, Porter, K |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2008
|
Podobné jednotky
-
Highly active antiretroviral therapy interruption: predictors and virological and immunologic consequences.
Autor: Touloumi, G, a další
Vydáno: (2006) -
The immunological and virological consequences of planned treatment interruptions in children with HIV infection
Autor: Klein, N, a další
Vydáno: (2013) -
CMV retinitis in an HIV patient with clinical and
immunological failure on HAART
Autor: Dipankar Chakraborty,, a další
Vydáno: (2015) -
Virological remission after antiretroviral therapy interruption in female African HIV seroconverters
Autor: Gossez, M, a další
Vydáno: (2018) -
Determinants of survival following HIV-1 seroconversion after the introduction of HAART.
Autor: Porter, K, a další
Vydáno: (2003)